Expression of HIV-1 Intron-Containing RNA in Microglia Induces Inflammatory Responses

• Published in: Journal of virology Vol. 95; no. 5
• Main Authors: Akiyama, Hisashi, Jalloh, Sallieu, Park, Seonmi, Lei, Maohua, Mostoslavsky, Gustavo, Gummuluru, Suryaram
• Format: Journal Article
• Language: English
• Published: United States American Society for Microbiology 01-03-2021
• Subjects: Pathogenesis and Immunity; HIV; neuroinflammation; microglia; intron-containing RNA; iPSC
• ISSN: 0022-538X; 1098-5514
• DOI: 10.1128/JVI.01386-20

Chronic neuroinflammation is observed in HIV
individuals on suppressive combination antiretroviral therapy (cART) and is thought to cause HIV-associated neurocognitive disorders. We have recently reported that expression of HIV intron-containing RNA (icRNA) in productively infected monocyte-derived macrophages induces pro-inflammatory responses. Microglia, yolk sac-derived brain-resident tissue macrophages, are the primary HIV-1 infected cell type in the central nervous system (CNS). In this study, we tested the hypothesis that persistent expression of HIV icRNA in primary human microglia induces innate immune activation. We established multiple orthogonal primary human microglia-like cell cultures including peripheral blood monocyte-derived microglia (MDMG) and induced pluripotent stem cell (iPSC)-derived microglia. Unlike MDMG, human iPSC-derived microglia (hiMG), which phenotypically mimic primary CNS microglia, were robustly infected with replication competent HIV-1, and establishment of productive HIV-1 infection and de novo viral gene expression led to pro-inflammatory cytokine production. Blocking of HIV-1 icRNA expression, but not multiply spliced viral RNA, either via infection with virus expressing a Rev-mutant deficient for HIV icRNA nuclear export or infection in the presence of small molecule inhibitor of CRM1-mediated viral icRNA nuclear export pathway, attenuated induction of innate immune responses. These studies suggest that Rev-CRM1-dependent nuclear export and cytosolic sensing of HIV-1 icRNA induces pro-inflammatory responses in productively infected microglia. Novel strategies targeting HIV icRNA expression specifically are needed to suppress HIV-induced neuroinflammation.